Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Toxic Financier's Lawyer is PTSC's Representative of PDS

Re: B-Lunist

posted on Apr 30, 2008 10:47AM

When it is done the Authorized shares stay the same, moxa

<<<<<<<<<...

You say that like it is a fact. It isn't. All shares are treated the same. They are all lessened (in the case of a RS) or increased (in the case of a forward split)

This reverse split will give Summus approximately 13.4 million shares of common stock outstanding. The Company's number of authorized shares of common stock will remain at 185,000,000, and its number of authorized shares of preferred stock will remain at 5,000,000.

http://findarticles.com/p/articles/m...

Be well

Share
New Message
Please login to post a reply